Vaccines represent a special class of drugs, capable of stimulating immune system responses against pathogens and tumors. Vaccine development is a lengthy process that includes expensive laboratory experiments in order to assess safety and effectiveness. As the efficacy of a vaccine was demonstrated by biological/chemical investigations and pre-clinical studies, then a major problem is represented by the search for an optimal vaccination dosage. Optimality here assumes the meaning of assuring a high degree of efficacy and safety (lack of toxic or side effects). In lack of quantitative methods, this is usually achieved by a consensus technique, a public statement on a particular aspect of medical knowledge available at the time it was written, and that is generally agreed upon as the evidence-based, state-of-the-art (or state-of-science) knowledge by a representative group of experts in that area. In this article, we focus on the difficult problem of the search for an optimal vaccination dosage in the field of tumor immunology, that is a major issue in biomedical research. This, indeed, represents a first step toward a personalized medicine approach.
|Titolo:||Vaccine protocols optimization: in silico experiences|
|Data di pubblicazione:||2010|
|Citazione:||Vaccine protocols optimization: in silico experiences / PAPPALARDO F; PENNISI M; CASTIGLIONE F; MOTTA S. - In: BIOTECHNOLOGY ADVANCES. - ISSN 0734-9750. - 28(2010), pp. 82-93.|
|Appare nelle tipologie:||1.1 Articolo in rivista|